Works matching DE "CYCLOOXYGENASE 2 inhibitors"

Results: 1335

CAL-B promoted amidation of (S)-ibuprofen: Mechanistic study and in vitro versus in silico evaluation of the anti-inflammatory activity.

Published in:

Biocatalysis & Biotransformation, 2025, v. 43, n. 3, p. 301, doi. 10.1080/10242422.2025.2495009

By:

Merabet-Khelassi, Mounia;
Kilani-Morakchi, Samira;
Sifi, Karima;
Zeror, Saoussen

Publication type:

Article

Celecoxib Shows Benefit in First-of-Its-Kind Lung Cancer Chemoprevention Trial.

Published in:: Oncology (08909091), 2008, v. 22, n. 8, p. 940
Publication type:: Article

A Comparison of Cost Effectiveness Using Data from Randomized Trials or Actual Clinical Practice: Selective Cox-2 Inhibitors as an Example.

Published in:

PLoS Medicine, 2009, v. 6, n. 12, p. 1, doi. 10.1371/journal.pmed.1000194

By:

van Staa, Tjeerd-Pieter;
Leufkens, Hubert G.;
Zhang, Bill;
Smeeth, Liam

Publication type:

Article

Paroxysmal Hemicrania: An Update.

Published in:

2021

By:

Paliwal, Vimal Kumar;
Uniyal, Ravi

Publication type:

journal article

Cell density influences the effect of celecoxib in two carcinoma cell lines.

Published in:

Biotechnic & Histochemistry, 2006, v. 81, n. 1, p. 51, doi. 10.1080/10520290600782947

By:

Vital-Reyes, Vs;
Rodríguez-Burford, C;
Oelschlager, Dk;
Grizzle, We

Publication type:

Article

Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate.

Published in:

Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 179, doi. 10.1111/vco.12760

By:

Alonso‐Miguel, Daniel;
Valdivia, Guillermo;
García‐San José, Paula;
Alonso‐Diez, Ángela;
Clares, Irene;
Portero, Miriam;
Peña, Laura;
Pérez‐Alenza, Maria Dolores

Publication type:

Article

COX-2 and c-kit expression in canine gliomas.

Published in:

Veterinary & Comparative Oncology, 2013, v. 11, n. 1, p. 63, doi. 10.1111/j.1476-5829.2011.00302.x

By:

Jankovsky, J. M.;
Newkirk, K. M.;
Ilha, M. R.;
Newman, S. J.

Publication type:

Article

Effect of cyclooxygenase inhibitors in a xenograft model of canine mammary tumours.

Published in:

Veterinary & Comparative Oncology, 2011, v. 9, n. 3, p. 161, doi. 10.1111/j.1476-5829.2010.00242.x

By:

Sonzogni-Desautels, K.;
Knapp, D. W.;
Sartin, E.;
Doré, M.

Publication type:

Article

Treatment of feline mammary tumours using chemotherapy, surgery and a COX-2 inhibitor drug (meloxicam): a retrospective study of 23 cases (2002–2007).

Published in:

Veterinary & Comparative Oncology, 2009, v. 7, n. 4, p. 213, doi. 10.1111/j.1476-5829.2009.00194.x

By:

Borrego, J. F.;
Cartagena, J. C.;
Engel, J.

Publication type:

Article

Enhanced antitumor effect of lower-dose and longer-term CPT-11 treatment in combination with low-dose celecoxib against neuroblastoma xenografts.

Published in:

International Journal of Clinical Oncology, 2013, v. 18, n. 1, p. 116, doi. 10.1007/s10147-011-0354-8

By:

Kaneko, Setsuko;
Kaneko, Michio;
Fukushima, Takashi

Publication type:

Article

Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis? A randomized double-blind placebo-controlled clinical trial.

Published in:

International Journal of Clinical Oncology, 2006, v. 11, n. 2, p. 133, doi. 10.1007/s10147-005-0548-z

By:

Iwama, Takeo;
Akasu, Takayuki;
Utsunomiya, Joji;
Muto, Tetsuichiro

Publication type:

Article

Preventive effects of COX-2 inhibitor, celecoxib on renal tubular injury induced by shock wave lithotriptor.

Published in:

Urological Research, 2010, v. 38, n. 4, p. 223, doi. 10.1007/s00240-009-0243-z

By:

Hyoung Keun Park;
Hae Won Lee;
Kwang Soo Lee;
Jong Sun Choi;
Byong Chang Jeong;
Hyeon Hoe Kim

Publication type:

Article

Erratum to: Preventive effects of COX-2 inhibitor, celecoxib on renal tubular injury induced by shock wave lithotriptor.

Published in:

2010

By:

Park, Hyoung;
Lee, Hae;
Lee, Kwang;
Choi, Jong;
Jeong, Byong;
Kim, Hyeon

Publication type:

Correction Notice

An animal model of calcium oxalate urolithiasis based on a cyclooxygenase 2 selective inhibitor.

Published in:

Urological Research, 2005, v. 33, n. 6, p. 453, doi. 10.1007/s00240-005-0507-1

By:

Byong Chang Jeong;
Min Young Park;
Cheol Kwak;
Bong Sub Kim;
Jung-In Kim;
Hyeon Hoe Kim

Publication type:

Article

Clinical use and pharmacological properties of selective COX-2 inhibitors.

Published in:

European Journal of Clinical Pharmacology, 2008, v. 64, n. 3, p. 233, doi. 10.1007/s00228-007-0400-7

By:

Shi, Shaojun;
Klotz, Ulrich

Publication type:

Article

The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor.

Published in:

European Journal of Clinical Pharmacology, 2005, v. 61, n. 4, p. 247, doi. 10.1007/s00228-005-0909-6

By:

Sarapa, Nenad;
Britto, Margaret R.;
Mainka, Michelle B.;
Parivar, Kourosh

Publication type:

Article

Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors.

Published in:

European Journal of Clinical Pharmacology, 2005, v. 61, n. 1, p. 55, doi. 10.1007/s00228-004-0865-6

By:

Behan, K.;
Cutts, C.;
Tett, Susan E.

Publication type:

Article

Does the early adopter of drugs exist? A population-based study of general practitioners’ prescribing of new drugs.

Published in:

European Journal of Clinical Pharmacology, 2004, v. 60, n. 9, p. 667, doi. 10.1007/s00228-004-0797-1

By:

Dybdahl, Torben;
Andersen, Morten;
Søndergaard, Jens;
Kragstrup, Jakob;
Kristiansen, Ivar

Publication type:

Article

Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database.

Published in:

European Journal of Clinical Pharmacology, 2004, v. 60, n. 9, p. 673, doi. 10.1007/s00228-004-0813-5

By:

Lugardon, S.;
Lapeyre-Mestre, M.;
Montastruc, J.

Publication type:

Article

Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study.

Published in:

European Journal of Clinical Pharmacology, 2004, v. 60, n. 7, p. 489, doi. 10.1007/s00228-004-0788-2

By:

Layton, Deborah;
Wilton, Lynda;
Shakir, Saad

Publication type:

Article

Chemoprevention of Gastric Cancer: Role of COX-2 Inhibitors and Other Agents.

Published in:

Digestive Diseases, 2004, v. 22, n. 4, p. 320, doi. 10.1159/000083593

By:

Nardone, Gerardo;
Rocco, Alba

Publication type:

Article

Identification of Bioactive Peptide Inhibitors of Cyclooxygenase-2 from Peanut Worm (Siphonosoma australe): An In Silico Studies.

Published in:

Trends in Sciences, 2025, v. 22, n. 5, p. 1, doi. 10.48048/tis.2025.9565

By:

Suwarjoyowirayatno;
Hidayat, Chusnul;
Wahyuningsih, Tutik Dwi;
Indrati, Retno

Publication type:

Article

The effect of oral administration of robenacoxib on hematological and biochemical parameters in different goat breeds.

Published in:

Veterinary Journal of Mehmet Akif Ersoy University, 2023, v. 8, n. 3, p. 206, doi. 10.24880/maeuvfd.1347911

By:

Kutahya, Zeynep Ozdemir;
Benli, Petek Piner

Publication type:

Article

Characterizing NSAID Allergy and Strategies for Management in Patients with Rheumatological and Orthopaedic Conditions, in a Single Tertiary Hospital in Hong Kong.

Published in:

2024

By:

Hooi, James;
Chu, Gordon Kwok Ho;
Wong, Jane Chi Yan;
Li, Philip

Publication type:

Abstract

Synthesis, Characterization, DFT, and In Silico Investigation of Two Newly Synthesized β-Diketone Derivatives as Potent COX-2 Inhibitors.

Published in:

Bioengineering (Basel), 2023, v. 10, n. 12, p. 1361, doi. 10.3390/bioengineering10121361

By:

Kurbanova, Malahat Musrat;
Maharramov, Abel Mammadali;
Sadigova, Arzu Zabit;
Gurbanova, Fidan Zaur;
Mali, Suraj Narayan;
Al-Salahi, Rashad;
El Bakri, Youness;
Lai, Chin-Hung

Publication type:

Article

Performance of the High-dimensional Propensity Score in a Nordic Healthcare Model.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2017, v. 120, n. 3, p. 312, doi. 10.1111/bcpt.12716

By:

Hallas, Jesper;
Pottegård, Anton

Publication type:

Article

Variability in the Response to Non-Steroidal Anti-Inflammatory Drugs: Mechanisms and Perspectives.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2014, v. 114, n. 1, p. 56, doi. 10.1111/bcpt.12117

By:

Bruno, Annalisa;
Tacconelli, Stefania;
Patrignani, Paola

Publication type:

Article

Chemoprevention of colorectal neoplasia.

Published in:

ANZ Journal of Surgery, 2017, v. 87, n. 12, p. E228, doi. 10.1111/ans.13392

By:

Wakeman, Chris;
Keenan, Jacqueline;
Eteuati, Jimmy;
Hollington, Paul;
Eglinton, Tim;
Frizelle, Frank

Publication type:

Article

Experimental Research on the Interactions between Selective COX-2 Inhibitors and Antidepressants.

Published in:

Medicina Moderna, 2015, v. 22, n. 2, p. 113

By:

Păunescu, Horia

Publication type:

Article

British Prostate Group BAUS Section of Oncology British Uro-Oncology Group.

Published in:: 2006
Publication type:: Abstract

Cyclooxygenase-2 expression is associated with chemoresistance through cancer stemness property in hypopharyngeal carcinoma.

Published in:

Oncology Letters, 2021, v. 22, n. 1, p. N.PAG, doi. 10.3892/ol.2021.12794

By:

Saito, Shin;
Ozawa, Hiroyuki;
Imanishi, Yorihisa;
Sekimizu, Mariko;
Watanabe, Yoshihiro;
Ito, Fumihiro;
Ikari, Yuichi;
Nakahara, Nana;
Kameyama, Kaori;
Ogawa, Kaoru

Publication type:

Article

Cyclooxygenase-2 is associated with malignant phenotypes in human lung cancer.

Published in:

Oncology Letters, 2016, v. 12, n. 5, p. 3836, doi. 10.3892/ol.2016.5207

By:

WEIYING LI;
WENTAO YUE;
HUI WANG;
BAITANG LAI;
XUEHUI YANG;
CHUNYAN ZHANG;
YUE WANG;
MENG GU

Publication type:

Article

Potency of non-steroidal anti-inflammatory drugs in chemotherapy (Review).

Published in:

Molecular & Clinical Oncology, 2015, v. 3, n. 1, p. 3, doi. 10.3892/mco.2014.446

By:

HIĽOVSKÁ, LUCIA;
JENDŽELOVSKÝ, RASTISLAV;
FEDOROČKO, PETER

Publication type:

Article

Protective effects of 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors on oxidative modification of human low density lipoproteins in vitro.

Published in:

Clinical Hemorheology & Microcirculation, 2015, v. 61, n. 4, p. 615, doi. 10.3233/CH-141923

By:

Pietzsch, Jens;
Laube, Markus;
Bechmann, Nicole;
Pietzsch, Franz-Jacob;
Kniess, Torsten

Publication type:

Article

Differential roles of cyclooxygenase enzymes in the regulation of murine juvenile undifferentiated spermatogonia.

Published in:

Andrology, 2024, v. 12, n. 4, p. 899, doi. 10.1111/andr.13537

By:

Tran‐Guzman, Amy;
Khan, Amina;
Culty, Martine

Publication type:

Article

UPLC-ESI-QTRAP-MS/MS Analysis to Quantify Bioactive Compounds in Fennel (Foeniculum vulgare Mill.) Waste with Potential Anti-Inflammatory Activity.

Published in:

Metabolites (2218-1989), 2022, v. 12, n. 8, p. 701, doi. 10.3390/metabo12080701

By:

Crescenzi, Maria Assunta;
D'Urso, Gilda;
Piacente, Sonia;
Montoro, Paola

Publication type:

Article

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00533

By:

Hidalgo-Estévez, Alicia M.;
Stamatakis, Konstantinos;
Jiménez-Martínez, Marta;
López-Pérez, Ricardo;
Fresno, Manuel

Publication type:

Article

Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy.

Published in:

Cell Proliferation, 2007, v. 40, n. 5, p. 768, doi. 10.1111/j.1365-2184.2007.00459.x

By:

Banu, N.;
Buda, A.;
Chell, S.;
Elder, D.;
Moorghen, M.;
Paraskeva, C.;
Qualtrough, D.;
Pignatelli, M.

Publication type:

Article

Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis.

Published in:

Journal of Gastroenterology, 2013, v. 48, n. 7, p. 830, doi. 10.1007/s00535-012-0717-6

By:

Jarupongprapa, Saharat;
Ussavasodhi, Prapassorn;
Katchamart, Wanruchada

Publication type:

Article

Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors.

Published in:

2013

By:

Lai, Shih-Wei;
Liao, Kuan-Fu

Publication type:

Letter

Reply to the letter regarding 'Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis'.

Published in:

2013

By:

Katchamart, Wanruchada

Publication type:

Letter

Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam.

Published in:

Journal of Gastroenterology, 2012, v. 47, n. 4, p. 387, doi. 10.1007/s00535-011-0501-z

By:

Maehata, Yuji;
Esaki, Motohiro;
Morishita, Toshibumi;
Kochi, Shuji;
Endo, Shingo;
Shikata, Kentaro;
Kobayashi, Hiroyuki;
Matsumoto, Takayuki

Publication type:

Article

Cyclooxygenase-2 inhibitors in patients with high gastrointestinal risk: are we there yet?

Published in:

Journal of Gastroenterology, 2009, v. 44, p. 53, doi. 10.1007/s00535-008-2260-z

By:

Wong, Vincent;
Chan, Francis

Publication type:

Article

Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy.

Published in:

Journal of Gastroenterology, 2009, v. 44, p. 64, doi. 10.1007/s00535-008-2248-8

By:

Maiden, Laurence

Publication type:

Article

NSAIDs and colorectal cancer prevention.

Published in:

Journal of Gastroenterology, 2009, v. 44, p. 72, doi. 10.1007/s00535-008-2265-7

By:

Iwama, Takeo

Publication type:

Article

Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats.

Published in:

Journal of Gastroenterology, 2006, v. 41, n. 3, p. 198, doi. 10.1007/s00535-005-1742-5

By:

Naito, Yuji;
Uchiyama, Kazuhiko;
Kuroda, Masaaki;
Takagi, Tomohisa;
Kokura, Satoshi;
Yoshida, Norimasa;
Ichikawa, Hiroshi;
Yoshikawa, Toshikazu

Publication type:

Article

Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.

Published in:

Journal of Gastroenterology, 2002, v. 37, n. 11, p. 896, doi. 10.1007/s005350200151

By:

Noda, Masao;
Tatsumi, Yoichi;
Tomizawa, Muneta;
Takama, Takafumi;
Mitsufuji, Shoji;
Sugihara, Hiroyuki;
Kashima, Kei;
Hattori, Takanori

Publication type:

Article

Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane.

Published in:

2002

By:

Kishimoto, Yosuke;
Yashima, Kazuo;
Morisawa, Tsuyoshi;
Shiota, Goshi;
Kawasaki, Hironaka;
Hasegawa, Junichi

Publication type:

journal article

Improvement in docetaxel-induced nail changes associated with cyclooxygenase-2 inhibitor treatment.

Published in:

2009

By:

Nakamura, S.;
Kajita, S.;
Takagi, A.;
Hashimoto, Y.;
Ishida-Yamamoto, A.;
Takahashi, H.;
Iizuka, H.

Publication type:

Letter

Celecoxib: A Review of its Use in the Management of Arthritis and Acute Pain.

Published in:

Drugs, 2007, v. 67, n. 16, p. 2433, doi. 10.2165/00003495-200767160-00008

By:

Frampton, James E.;
Keating, Gillian M.

Publication type:

Article